Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Bulletin Du Cancer
|
October 20, 2018
[Cytoreduction nephrectomy: No future?]
Loic Balssa, François Kleinclauss, Hamadi Almotlak, et al.
Clinical Genitourinary Cancer
|
October 26, 2017
Factors Influencing Overall Survival for Patients With Metastatic Clear-Cell Renal-Cell Carcinoma in Daily Practice
Antoine Thiery-Vuillemin, Tiphaine Cholley, Fabien Calcagno, et al.
Molecular and Clinical Oncology
|
January 26, 2016
Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study
Matthieu Caubet, Erion Dobi, Astrid Pozet, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 28, 2012
Specific anticancer treatments in the last 3 months of life: a French experience
Erika Viel, Loïc Chaigneau, Eleonor Fanton, et al.
Bulletin Du Cancer
|
June 27, 2022
Metastatic renal cell cancer and first-line combinations: for which patients? (focus on tolerance and health-related quality of life)
Antoine El Kaddissi, Guillemette Guilhem Ducleon, Félix Lefort, et al.
Frontiers in Oncology
|
March 28, 2022
Interest of the Addition of Taxanes to Standard Treatment in First-Line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients
Emeline Orillard, Julie Henriques, Dewi Vernerey, et al.
Trials
|
April 14, 2018
Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trial
Guillaume Mouillet, Marie-Justine Paillard, Tristan Maurina, et al.
Bulletin Du Cancer
|
July 5, 2020
[Systemic treatment of locally advanced or metastatic penile cancer]
Noémie Gassian, Alexandre Frontczak, Antoine El Kaddissi, et al.
BMC Cancer
|
May 13, 2022
Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer
Guillaume Eberst, Dewi Vernerey, Caroline Laheurte, et al.
World Journal of Gastrointestinal Oncology
|
March 25, 2020
FOLFOXIRI <i>vs</i> FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study
Angélique Vienot, Hortense Chevalier, Clément Bolognini, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Bulletin Du Cancer
|
October 20, 2018
[Cytoreduction nephrectomy: No future?]
Loic Balssa, François Kleinclauss, Hamadi Almotlak, et al.
Clinical Genitourinary Cancer
|
October 26, 2017
Factors Influencing Overall Survival for Patients With Metastatic Clear-Cell Renal-Cell Carcinoma in Daily Practice
Antoine Thiery-Vuillemin, Tiphaine Cholley, Fabien Calcagno, et al.
Molecular and Clinical Oncology
|
January 26, 2016
Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study
Matthieu Caubet, Erion Dobi, Astrid Pozet, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 28, 2012
Specific anticancer treatments in the last 3 months of life: a French experience
Erika Viel, Loïc Chaigneau, Eleonor Fanton, et al.
Bulletin Du Cancer
|
June 27, 2022
Metastatic renal cell cancer and first-line combinations: for which patients? (focus on tolerance and health-related quality of life)
Antoine El Kaddissi, Guillemette Guilhem Ducleon, Félix Lefort, et al.
Frontiers in Oncology
|
March 28, 2022
Interest of the Addition of Taxanes to Standard Treatment in First-Line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients
Emeline Orillard, Julie Henriques, Dewi Vernerey, et al.
Trials
|
April 14, 2018
Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trial
Guillaume Mouillet, Marie-Justine Paillard, Tristan Maurina, et al.
Bulletin Du Cancer
|
July 5, 2020
[Systemic treatment of locally advanced or metastatic penile cancer]
Noémie Gassian, Alexandre Frontczak, Antoine El Kaddissi, et al.
BMC Cancer
|
May 13, 2022
Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer
Guillaume Eberst, Dewi Vernerey, Caroline Laheurte, et al.
World Journal of Gastrointestinal Oncology
|
March 25, 2020
FOLFOXIRI <i>vs</i> FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study
Angélique Vienot, Hortense Chevalier, Clément Bolognini, et al.
Page
of 2